Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-α induced morphological change of human endothelial cells in vitro

Matrix Biology

Volumn 17, Issue 4, 1998, Pages 293-304

  Nelimarkka, Lassi O ^a,d   Nikkari, Seppo T ^c   Ravanti, Laura S ^a,b   Kähäri, Veli Matti ^a,b   Järveläinen, Hannu T ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Endothelial cells; Matrix metalloproteinase; Tissue inhibitor of matrix metalloproteinase; Tumor necrosis factor

Indexed keywords

BIGLYCAN; COLLAGENASE; GELATINASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROTEOGLYCAN; STROMELYSIN; SYNDECAN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL SHAPE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 0031687767     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(98)90082-8     Document Type: Article

References (67)

1. Badimon, L., Badimon, J.J., Penny, W., Webster, M.W., Chesebro, J.H. and Fuster, V.: Endothelium and atherosclerosis. J. Hypertens. 10: S43-50, 1992.
2. Bidanset, D.J., LeBaron, R., Rosenberg, L., Murphy-Ullrich, J.E. and Hook, M.: Regulation of cell substrate adhesion: effects of small galactosaminoglycan-containing proteoglycans. J. Cell Biol. 118: 1523-1531, 1992.
3. Birkedal-Hansen, H., Moore, W.G., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A. and Engler, J.A.: Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4: 197-250, 1993.
4. Bradley, J.R. and Pober, J.S.: Prolonged cytokine exposure causes a dynamic redistribution of endothelial cell adhesion molecules to intercellular junctions.Lab. Invest.75: 463-472, 1996.
5. Brennan, F.M., Browne, K.A., Green, P.A., Jaspar, J.M., Maini, R.N. and Feldmann, M.: Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-α (cA2) therapy. Br. J. Rheumatol. 36: 643-650, 1997.
6. Burnette, W.N.: "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112: 195-203, 1981.
7. Carmichael, D.F., Sommer, A., Thompson, R.C., Anderson, D.C., Smith, C.G., Welgus, H.G. and Stricklin, G.P.: Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc. Natl. Acad. Sci. USA 83: 2407-2411, 1986.
8. Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
9. Corder, R., Khan, N. and Harrison, V.J.: A simple method for isolating human endothelin converting enzyme free from contamination by neutral endopeptidase 24.11. Biochem. Biophys. Res. Commun. 207: 355-362, 1995.
10. Cornelius, L.A., Nehring, L.C., Roby, J.D., Parks, W.C. and Welgus, H.G.: Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J. Invest. Dermatol. 105: 170-176, 1995.
11. Edgell, C.J., McDonald, C.C. and Graham, J.B.: Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80: 3734-3737, 1983.
12. Elenius, K. and Jalkanen, M.: Function of the syndecans - a family of cell surface proteoglycans. J. Cell Sci. 107: 2975-2982, 1994.
13. Emeis, J.J. and Edgell, C.J.: Fibrinolytic properties of a human endothelial hybrid cell line (EA.hy 926). Blood 71: 1669-1675, 1988.
14. Foda, H.D., George, S., Conner, C., Drews, M., Tompkins, D.C. and Zucker, S.: Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab. Invest. 74: 538-545, 1996.
15. Fort, P., Marty, L., Piechaczyk, M., el-Sabrouty, S., Dani, C., Jeanteur, P. and Blanchard, J.M.: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13: 1431-1442, 1985.
16. Galis, Z.S., Muszynski, M., Sukhova, G.K., Simon-Morrissey, E. and Libby, P.: Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann. NY Acad. Sci. 748: 501-507, 1995a.
17. Galis, Z.S., Sukhova, G.K., Lark, M.W. and Libby, P.: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94: 2493-2503, 1994.
18. Galis, Z.S., Sukhova, G.K. and Libby, P.: Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 9: 974-980, 1995b.
19. Gimbrone, M., Jr.: Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis. Am. J. Cardiol. 75: 67B-70B, 1995.
20. Goldberg, G.I., Wilhelm, S.M., Kronberger, A., Bauer, E.A., Grant, G.A. and Eisen, A.Z.: Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J. Biol. Chem. 261: 6600-6605, 1986.
21. Greene, J., Wang, M., Liu, Y.E., Raymond, L.A., Rosen, C. and Shi, Y.E.: Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271: 30375-30380, 1996.
22. Halpert, I., Sires, U.I., Roby, J.D., Potter-Perigo, S., Wight, T.N., Shapiro, S.D., Welgus, H.G., Wickline, S.A. and Parks, W.C.: Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl. Acad. Sci. USA 93: 9748-9753, 1996.
23. Hanemaaijer, R., Koolwijk, P., le Clercq, L., de Vree, W.J. and van Hinsbergh, V.W.: Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor-α, interleukin-1 and phorbol ester. Biochem. J. 296: 803-809, 1993.
24. Huhtala, P., Chow, L.T. and Tryggvason, K.: Structure of the human type IV collagenase gene. J. Biol. Chem. 265: 11077-11082, 1990.
25. Ito, A., Sato, T., Iga, T. and Mori, Y.: Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases (TIMP) production by human fibroblasts. FEBS J. 269: 93-95, 1990.
26. Järveläinen, H.T., Kinsella, M.G., Wight, TN. and Sandell, L.J.: Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J. Biol. Chem. 266: 23274-23281, 1991.
27. Jasser, M.Z., Mitchell, B.G. and Cheung, H.S.: Induction of stromelysin-1 and collagenase synthesis in fibrochondrocytes by tumor necrosis factor-α. Matrix Biol. 14: 241-249, 1994.
28. Johansson, N., Westermarck, J., Leppä, S., Häkkinen, L., Koivisto, L., López-Otín, C., Peltonen, J., Heino, J. and Kähäri, V.-M.: Collagenase-3 (matrix metalloproteinase-13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor-α and transforming growth factor-αβ. Cell Growth Differ. 8: 243-250, 1997.
29. Kähäri, V-M. and Saarialho-Kere, U.: Matrix metalloproteinases in skin. Exp. Dermatol. 6: 199-213, 1997.
30. Kainulainen, V., Nelimarkka, L., Järveläinen, H., Laato, M., Jalkanen, M. and Elenius, K.: Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-α. J. Biol. Chem. 271: 18759-18766, 1996.
31. Kawashima, A., Nakanishi, I., Tsuchiya, H., Roessner, A., Obata, K. and Okada, Y.: Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor-α correlates with metastatic ability in a human osteosarcoma cell line. Virchows Arch. 424: 547-552, 1994.
32. Kenagy, R.D. and Clowes, A.W.: A possible role for MMP-2 and MMP-9 in the migration of primate arterial smooth muscle cells through native matrix. Ann. NY Acad. Sci. 732: 462-465, 1994.
33. Laemmli, U.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
34. Lafrenie, R., Shaughnessy, S.G. and Orr, F.W.: Cancer cell interactions with injured or activated endothelium. Cancer Metast. Rev. 11: 377-388, 1992.
35. Lampugnani, M.G., Resnati, M., Dejana, E. and Marchisio, P.C.: The role of integrins in the maintenance of endothelial monolayer integrity. J. Cell Biol. 112: 479-490, 1991.
36. Leco, K.J., Khokha, R., Pavloff, N., Hawkes, S.P. and Edwards, D.R.: Tissue inhibitor of metalloproteinase-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269: 9352-9360, 1994.
37. Lefer, A.M. and Ma, X.L.: Cytokines and growth factors in endothelial dysfunction. Crit. Care Med. 21: S9-14, 1993.
38. Lindy, O., Konttinen, Y.T., Sorsa, T., Ding, Y., Santavirta, S., Ceponis, A. and Eopez-Otin, C.: Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum. 40: 1391-1399, 1997.
39. Llano, E., Pendás, A.M., Knäuper, V., Sorsa, T., Salo, T., Salido, E., Murphy, G., Simmer, J.P., Bartlett, J.D. and López-Otín, C.: Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36: 15101-15108, 1997.
40. Lohi, J., Lehti, K., Westermarck, J., Kähäri, V.-M. and Keskioja, J.: Regulation of membrane-type matrix metalloproteinase-1 (MT-MMP-1) expression by growth factors and the phorbol ester PMA. Eur. J. Biochem. 239: 239-247, 1996.
41. Lum, H. and Malik, A.B.: Regulation of vascular endothelial barrier function. Am. J. Physiol. 267: E223-241, 1994.
42. Mackay, A.R., Ballin, M., Pelina, M.D., Farina, A.R., Nason, A.M., Hartzler, J.L. and Thorgeirsson, U.P.: Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metast. 12: 168-184, 1992.
43. Mattila, L., Airola, K., Ahonen, M., Hietarinta, M., Black, C., Saarialho-Kere, U. and Kähäri, V-M.: Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J. Invest. Dermatol. 110: 416-421, 1998.
44. Migita, K., Eguchi, K., Kawabe, Y., Ichinose, Y., Tsukada, T., Aoyagi, T., Nakamura, H. and Nagataki, S.: TNF-α-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 89: 553-557, 1996.
45. Muller, D., Quantin, B., Gesnel, M.C., Millon-Collard, R., Abecassis, J. and Breathnach, R.: The collagenase gene family in humans consists of at least four members. Biochem. J. 253: 187-192, 1988.
46. Nelimarkka, L., Kainulainen, V., Schönherr, F., Moisander, S., Jortikka, M., Lammi, M., Elenius, K., Jalkanen, M. and Järveläinen, H.: Expression of small extracellular chondroitin/dermatan sulfate proteoglycans is differentially regulated in human endothelial cells. J. Biol. Chem. 272: 12730-12737, 1997.
47. Nikkari, S.T., Geary, R.L., Hatsukami, T., Ferguson, M., Forough, R., Alpers, C.E. and Clowes, A.W.: Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy. Am. J. Pathol. 148: 777-783, 1996.
48. Nikkari, S.T., O'Brien, K.D., Ferguson, M., Hatsukami, T., Welgus, H.G., Alpers, C.E. and Clowes, A.W.: Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92: 1393-1398, 1995.
49. Partridge, C.A., Jeffrey, J.J. and Malik, A.B.: A 96-kDa gelatinase induced by TNF-α contributes to increased microvascular endothelial permeability. Am. J. Physiol. 265: L438-447, 1993.
50. Partridge, C.A., Phillips, P.G., Niedbala, M.J. and Jeffrey, J.J.: Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts. Am. J. Physiol. Lung Cell Mol. Physiol. 272: L813-822, 1997.
51. Pober, J.S. and Cotran, R.S.: Cytokines and endothelial cell biology. Physiol. Rev. 70: 427-451, 1990.
52. Ross, R.: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
53. Ross, R., Faggiotto, A., Bowen-Pope, D. and Raines, E.: The role of endothelial injury and platelet and macrophage interactions in atherosclerosis. Circulation 70: III77-82, 1984.
54. Saarialho-Kere, U.K., Vaalamo, M., Puolakkainen, P., Airola, K., Parks, W.C. and Karjalainen-Lindsberg, M.L.: Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am. J. Pathol. 148: 519-526, 1996.
55. Sarén, P., Welgus, H.G. and Kovanen, P.T.: TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J. Immunol. 157: 4159-4165, 1996.
56. Sato, N., Goto, T., Haranaka, K., Satomi, N., Nariuchi, H., Mano-Hirano, Y. and Sawasaki, Y.: Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J. Natl. Cancer Inst., 76: 1113-1121, 1986.
57. Savage, C.O. and Cooke, S.P.: The role of the endothelium in systemic vasculitis. J. Autoimmun. 6: 237-249, 1993.
58. Schnaper, H.W., Grant, D.S., Stetler-Stevenson, W.G., Fridman, R., D'Orazi, G., Murphy, A.N., Bird, R.E., Hoythya, M., Fuerst, T.R., French, D.L. et al.: Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell Physiol. 156: 235-246, 1993.
59. Schwartz, S.M.: Disturbances in endothelial integrity. Ann. NY Acad. Sci. 401: 228-233, 1982.
60. Ståhle-Bäckdahl, M., Sudbeck, B.D., Eisen, A.Z., Welgus, H.G. and Parks, W.C.: Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma. J. Invest. Dermatol. 99: 497-503, 1992.
61. Stetler-Stevenson, W.G., Krutzsch, H.C. and Liotta, L.A.: Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264: 17374-17378, 1989.
62. Stolpen, A.H., Guinan, E.C., Fiers, W. and Pober, J.S.: Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am. J. Pathol. 123: 16-24, 1986.
63. Tracey, K.J. and Cerami, A.: Tumor necrosis factor: an updated review of its biology. Crit. Care Med. 21: S415-422, 1993.
64. Westermarck, J., Häkkinen, L., Fiers, W. and Kähäri, V.M.: TNF-R55-specific form of human tumor necrosis factor-α induces collagenase gene expression by human skin fibroblasts. J. Invest. Dermatol. 105: 197-202, 1995.
65. Wight, T.N.: Cell biology of arterial proteoglycans. Arteriosclerosis 9: 1-20, 1989.
66. Wight, T.N.: The extracellular matrix and atherosclerosis. Curr. Opin. Lipidol. 6: 326-334, 1995.
67. Yao, P.M., Maitre, B., Delacourt, C., Buhler, J.M., Harf, A. and Lafuma, C.: Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1β and TNF-α. Am. J. Physiol. Lung Cell Mol. Physiol. 273: L866-874, 1997.